Literature DB >> 9461535

Characterization of mini-protein S, a recombinant variant of protein S that lacks the sex hormone binding globulin-like domain.

M Van Wijnen1, J G Stam, G T Chang, J C Meijers, P H Reitsma, R M Bertina, B N Bouma.   

Abstract

Protein S is a vitamin K-dependent glycoprotein involved in the regulation of the anticoagulant activity of activated protein C (APC). Also, an anticoagulant role for protein S, independent of APC, has been described. Protein S has a unique C-terminal sex hormone binding globulin (SHBG)-like domain that represents about half of the molecule. To define the role of this domain in APC cofactor activity and in binding to C4b-binding protein (C4BP), we have constructed a recombinant protein S molecule of N-terminal residues 1-242 that lacks the SHBG domain (mini-protein S). A panel of monoclonal antibodies directed against the N-terminal region of protein S recognized plasma-derived protein S, wild-type recombinant protein S and mini-protein S with similar affinities, whereas a monoclonal antibody that recognizes an epitope in the SHBG domain did not detect mini-protein S. Mini-protein S did not bind to C4BP in a solid-phase binding assay, and the cofactor activity of mini-protein S was not inhibited by preincubation with C4BP. In a plasma coagulation assay, the cofactor activity of mini-protein S was lower than wild-type or plasma-derived preparations. In contrast, no difference in APC cofactor activities was observed when the preparations were tested in purified systems that monitor the APC-mediated degradation of factors Va or VIIIa. In conclusion, we constructed a protein S molecule that fails to bind C4BP and still displays cofactor activity for APC. This confirms the role of the C-terminal SHBG region in C4BP binding and demonstrates that N-terminal residues 1-242 are sufficient for the expression of APC cofactor activity in a system using purified components. In plasma, however, the C-terminal SHBG region plays a role in the expression of optimal APC cofactor activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9461535      PMCID: PMC1219152          DOI: 10.1042/bj3300389

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  49 in total

1.  Single bilayer vesicles prepared without sonication. Physico-chemical properties.

Authors:  J Brunner; P Skrabal; H Hauser
Journal:  Biochim Biophys Acta       Date:  1976-12-02

Review 2.  Protein S deficiency.

Authors:  D Borgel; S Gandrille; M Aiach
Journal:  Thromb Haemost       Date:  1997-07       Impact factor: 5.249

3.  Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots.

Authors:  G Rouser; S Fkeischer; A Yamamoto
Journal:  Lipids       Date:  1970-05       Impact factor: 1.880

4.  Increased prothrombin activation in protein S-deficient plasma under flow conditions on endothelial cell matrix: an independent anticoagulant function of protein S in plasma.

Authors:  C van't Veer; T M Hackeng; D Biesbroeck; J J Sixma; B N Bouma
Journal:  Blood       Date:  1995-04-01       Impact factor: 22.113

5.  Purification and characterization of human coagulation factor V.

Authors:  W H Kane; P W Majerus
Journal:  J Biol Chem       Date:  1981-01-25       Impact factor: 5.157

6.  A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S.

Authors:  R G Di Scipio; M A Hermodson; S G Yates; E W Davie
Journal:  Biochemistry       Date:  1977-02-22       Impact factor: 3.162

7.  Isolation and characterization of single chain bovine factor V.

Authors:  M E Nesheim; K H Myrmel; L Hibbard; K G Mann
Journal:  J Biol Chem       Date:  1979-01-25       Impact factor: 5.157

8.  Characterization of protein S, a gamma-carboxyglutamic acid containing protein from bovine and human plasma.

Authors:  R G DiScipio; E W Davie
Journal:  Biochemistry       Date:  1979-03-06       Impact factor: 3.162

9.  Human plasma protein C: isolation, characterization, and mechanism of activation by alpha-thrombin.

Authors:  W Kisiel
Journal:  J Clin Invest       Date:  1979-09       Impact factor: 14.808

10.  Regulation of activated protein C by protein S. The role of phospholipid in factor Va inactivation.

Authors:  F J Walker
Journal:  J Biol Chem       Date:  1981-11-10       Impact factor: 5.157

View more
  8 in total

1.  Chemical synthesis and spontaneous folding of a multidomain protein: anticoagulant microprotein S.

Authors:  T M Hackeng; J A Fernández; P E Dawson; S B Kent; J H Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

2.  The Journey of Protein S from an Anticoagulant to a Signaling Molecule.

Authors:  V S Pilli; William Plautz; Rinku Majumder
Journal:  JSM Biochem Mol Biol       Date:  2016-08-08

3.  Implication of protein S thrombin-sensitive region with membrane binding via conformational changes in the gamma-carboxyglutamic acid-rich domain.

Authors:  D Borgel; P Gaussem; C Garbay; C Bachelot-Loza; T Kaabache; W Q Liu; B Brohard-Bohn; B Le Bonniec; M Aiach; S Gandrille
Journal:  Biochem J       Date:  2001-12-01       Impact factor: 3.857

Review 4.  Sex hormone-binding globulin: not only a transport protein. What news is around the corner?

Authors:  N Fortunati
Journal:  J Endocrinol Invest       Date:  1999-03       Impact factor: 4.256

5.  Dependence on vitamin K-dependent protein S for eukaryotic cell secretion of the beta-chain of C4b-binding protein.

Authors:  Sofia Carlsson; Björn Dahlbäck
Journal:  J Biol Chem       Date:  2010-08-06       Impact factor: 5.157

6.  Plasma protein S contains zinc essential for efficient activated protein C-independent anticoagulant activity and binding to factor Xa, but not for efficient binding to tissue factor pathway inhibitor.

Authors:  Mary J Heeb; Duane Prashun; John H Griffin; Bonno N Bouma
Journal:  FASEB J       Date:  2009-02-24       Impact factor: 5.191

7.  TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain.

Authors:  Natalia Reglińska-Matveyev; Helena M Andersson; Suely M Rezende; Björn Dahlbäck; James T B Crawley; David A Lane; Josefin Ahnström
Journal:  Blood       Date:  2014-04-16       Impact factor: 22.113

8.  Population-specific single-nucleotide polymorphism confers increased risk of venous thromboembolism in African Americans.

Authors:  Roxana Daneshjou; Larisa H Cavallari; Peter E Weeke; Konrad J Karczewski; Katarzyna Drozda; Minoli A Perera; Julie A Johnson; Teri E Klein; Carlos D Bustamante; Dan M Roden; Christian Shaffer; Joshua C Denny; James L Zehnder; Russ B Altman
Journal:  Mol Genet Genomic Med       Date:  2016-06-21       Impact factor: 2.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.